Issued Patents All Time
Showing 1–25 of 38 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12226417 | Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists | Hazel Hunt, Onno C. Meijer, José van den Heuvel | 2025-02-18 |
| 12109272 | Intermittent dosing of glucocorticoid receptor modulators for the treatment of ovarian and other cancers | Stacie Shepherd | 2024-10-08 |
| 12097210 | Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors | — | 2024-09-24 |
| 11969435 | Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors | — | 2024-04-30 |
| 11903945 | Methods of treating antipsychotic-induced weight gain with miricorilant | Ada Lee, Hazel Hunt | 2024-02-20 |
| 11890289 | Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency | Andreas G. Moraitis, Pejman Cohan | 2024-02-06 |
| 11590135 | Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists | Hazel Hunt, Onno C. Meijer, José van den Heuvel | 2023-02-28 |
| 11268145 | Methods for treating Cushing's syndrome | Hazel Hunt, John Francis Unitt, Andreas G. Moraitis | 2022-03-08 |
| 11202784 | Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency | Andreas G. Moraitis, Pejman Cohan | 2021-12-21 |
| 11173165 | Optimizing mifepristone levels for Cushing's patients | Coleman Gross | 2021-11-16 |
| 11103514 | Treatment of muscular dystrophy | — | 2021-08-31 |
| 10881660 | Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists | Hazel Hunt, Onno C. Meijer, José van den Heuvel | 2021-01-05 |
| 10842800 | Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors | — | 2020-11-24 |
| 10660904 | Optimizing mifepristone levels for cushing's patients | Coleman Gross | 2020-05-26 |
| 10610534 | Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency | Andreas G. Moraitis, Pejman Cohan | 2020-04-07 |
| 10604807 | Methods for diagnosing and assessing treatment for Cushing's syndrome | Hazel Hunt, John Francis Unitt, Andreas G. Moraitis | 2020-03-31 |
| 10238659 | Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists | Hazel Hunt, Onno C. Meijer, José van den Heuvel | 2019-03-26 |
| 10195214 | Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors | — | 2019-02-05 |
| 10166243 | Optimizing mifepristone levels for cushing'S patients | Coleman Gross | 2019-01-01 |
| 10166242 | Optimizing mifepristone levels for Cushing's patients | Coleman Gross | 2019-01-01 |
| 9943526 | Optimizing mifepristone levels for cushing's patients | Coleman Gross | 2018-04-17 |
| 8921348 | Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists | — | 2014-12-30 |
| 8741880 | Antiglucocorticoid therapy for the prevention of neurological damage in premature infants | — | 2014-06-03 |
| 8598149 | Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists | — | 2013-12-03 |
| 8476254 | Methods for treating psychosis associated with interferson-α therapy | — | 2013-07-02 |